Skip to content

GCRI Screening Finds High HPV Rates Among HIV-Positive Women

By News Analysis India · · 1 min read

The Gujarat Cancer Research Institute has been conducting targeted cervical‑cancer screening for women living with HIV. Using HPV DNA testing, the institute screened 1,542 patients at the ART centre of Civil Hospital, Ahmedabad, and found that 319 women (about one in five) carried the high‑risk HPV infection.

A subset of 150 women received colposcopic follow‑up, revealing 94 instances of cervical intra‑epithelial neoplasia – 63 at CIN 1, 30 at CIN 2 and one case progressing to CIN 3. An early‑stage cervical carcinoma was also identified, enabling early therapeutic intervention.

These findings contrast sharply with the state‑wide HPV prevalence of roughly 5 % in urban and rural communities. The initiative earned the FICCI Healthcare Excellence Award 2026 for outstanding patient care integration. Building on this success, Gujarat’s health department intends to extend the integrated screening framework to all ART sites, aiming to strengthen preventive health measures and improve access to early diagnosis.